Reva Basho, MD

Dr. Reva Basho is the Chief Medical Officer at the Ellison Medical Institute. She is a breast medical oncologist and a clinical investigator.

Dr. Basho received her undergraduate training at Rice University and her medical degree from Baylor College of Medicine. She completed her Internal Medicine residency at UCLA Medical Center and her Hematology and Oncology fellowship at MD Anderson Cancer Center.

Alongside her clinical practice, Dr. Basho is a respected and nationally-recognized clinical investigator. Her research focuses on the development of novel therapies for the treatment of high-risk breast cancers. Her specific interests include targeting the PI3K pathway and the development of novel immune therapies. She has served as the PI of numerous clinical trials, serves on several steering committees for international phase 3 clinical trials, and is currently leading a sub-study of the National Cancer Institute’s ComboMATCH trial.

Dr. Basho has authored many research articles, book chapters, and abstracts. She is active in national organizations including the American Society of Clinical Oncology, American Association for Cancer Research, and the Southwest Oncology Group. She has previously served as a member of the National Cancer Institute’s working group for neoadjuvant clinical endpoints. Dr. Basho is also passionate about mentoring medical students and trainees.